Recent studies highlight the JAK-STAT pathway’s role in inflammation, cancer, and neurodegenerative diseases, linking cytokine release and immune regulation to NAFLD pathogenesis (131). Here, SOAT1 is linked to metabolic dysfunction-associated steatotic liver disease.